Saylors RL - Search Results

1

Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients.

Morrow WR, Frazier EA, Mahle WT, Harville TO, Pye SE, Knecht KR, Howard EL, Smith RN, Saylors RL, Garcia X, Jaquiss RD, Woodle ES. Morrow WR, et al. Among authors: saylors rl. Transplantation. 2012 Feb 15;93(3):319-24. doi: 10.1097/TP.0b013e31823f7eea. Transplantation. 2012. PMID: 22179403 Free PMC article.

2

Treatment of deep vein thrombosis with enoxaparin in pediatric cancer patients receiving chemotherapy.

Stine KC, Saylors RL, Saccente CS, Becton DL. Stine KC, et al. Among authors: saylors rl. Clin Appl Thromb Hemost. 2007 Apr;13(2):161-5. doi: 10.1177/1076029606298989. Clin Appl Thromb Hemost. 2007. PMID: 17456625 Free article.

3

2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients.

Stine KC, Saylors RL, Williams LL, Becton DL. Stine KC, et al. Among authors: saylors rl. Med Pediatr Oncol. 1997 Oct;29(4):288-92. doi: 10.1002/(sici)1096-911x(199710)29:4<288::aid-mpo9>3.0.co;2-i. Med Pediatr Oncol. 1997. PMID: 9251735

4

Comparison of automated red cell exchange transfusion and simple transfusion for the treatment of children with sickle cell disease acute chest syndrome.

Saylors RL, Watkins B, Saccente S, Tang X. Saylors RL, et al. Pediatr Blood Cancer. 2013 Dec;60(12):1952-6. doi: 10.1002/pbc.24744. Epub 2013 Sep 2. Pediatr Blood Cancer. 2013. PMID: 24000077

5

Biomarkers for risk stratification of febrile neutropenia among children with malignancy: a pilot study.

Mian A, Becton D, Saylors R, James L, Tang X, Bhutta A, Prodhan P. Mian A, et al. Pediatr Blood Cancer. 2012 Aug;59(2):238-45. doi: 10.1002/pbc.24158. Epub 2012 Apr 25. Pediatr Blood Cancer. 2012. PMID: 22535591

6

Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis.

Stine KC, Saylors RL, Saccente S, McClain KL, Becton DL. Stine KC, et al. Among authors: saylors rl. Pediatr Blood Cancer. 2004 Jul;43(1):81-4. doi: 10.1002/pbc.20053. Pediatr Blood Cancer. 2004. PMID: 15170896 Clinical Trial.

7

Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.

Saylors RL 3rd, Stine KC, Sullivan J, Kepner JL, Wall DA, Bernstein ML, Harris MB, Hayashi R, Vietti TJ; Pediatric Oncology Group. Saylors RL 3rd, et al. J Clin Oncol. 2001 Aug 1;19(15):3463-9. doi: 10.1200/JCO.2001.19.15.3463. J Clin Oncol. 2001. PMID: 11481351 Clinical Trial.

8

Long-term survival in osteosarcoma patients following retinoblastoma using doxorubicin, cisplatin, and methotrexate.

Stine KC, Saylors RL, Saccente S, Becton DL. Stine KC, et al. Among authors: saylors rl. Med Pediatr Oncol. 2003 Jul;41(1):77-8. doi: 10.1002/mpo.10311. Med Pediatr Oncol. 2003. PMID: 12764753 No abstract available.

9

Secondary acute myelogenous leukemia following safe exposure to etoposide.

Stine KC, Saylors RL, Sawyer JR, Becton DL. Stine KC, et al. Among authors: saylors rl. J Clin Oncol. 1997 Apr;15(4):1583-6. doi: 10.1200/JCO.1997.15.4.1583. J Clin Oncol. 1997. PMID: 9193356

10

KRN5500 induces apoptosis (PCD) of myeloid leukemia cell lines and patient blasts.

Stine KC, Warren BA, Saylors RL, Becton DL. Stine KC, et al. Among authors: saylors rl. Leuk Res. 2000 Sep;24(9):741-9. doi: 10.1016/s0145-2126(00)00040-0. Leuk Res. 2000. PMID: 10978778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters